Charles Ruohua Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Charles Ruohua Liu has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Kreisel
Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, MO, USA
5 shared publications - Jon H. Ritter
Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA
5 shared publications - Yuriko Terada
Surgery, Washington University School of Medicine, St. Louis, MO, USA
5 shared publications - Alexander Sasha Krupnick
Department of Surgery, University of Maryland, Baltimore, MD, USA
4 shared publications - Andrew E. Gelman
Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, United States of America
4 shared publications - Junedh M. Amrute
Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, USA
4 shared publications
Latest Publications
- Open Access
- 16 July 2026
- Published by Elsevier in American Journal of Transplantation
Recipient interleukin-1β production is critical for lung allograft acceptance
- 16 July 2026
- Published by Elsevier in American Journal of Transplantation
Open AccessRecipient interleukin-1β production is critical for lung allograft acceptance
- Open Access
- 6 June 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (11) , 2458-2470
Myeloid-avid mammalian target of rapamycin-inhibiting nanobiologic attenuates allograft fibrosis after lung transplantation
- 6 June 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (11) , 2458-2470
Open AccessMyeloid-avid mammalian target of rapamycin-inhibiting nanobiologic attenuates allograft fibrosis after lung transplantation
- Open Access
- 30 April 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (9) , 2047-2061
Circulating T cell-specific extracellular vesicles as biomarkers of acute cellular rejection after lung transplantation
- 30 April 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (9) , 2047-2061
Open AccessCirculating T cell-specific extracellular vesicles as biomarkers of acute cellular rejection after lung transplantation
- 25 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (838) , eadu0358
Lymphatic disruption drives lung transplant fibrosis through interleukin-1–mediated hyaluronan accumulation
The consequence of lymphatic disruption during transplantation of solid organs remains unknown. Long-term survival after organ transplantation is limited by chronic rejection, a poorly understood process involving fibrotic remodeling and functional decline of the graft. Here, we found that transplanted human lungs and hearts with chronic rejection exhibited fibrosis distributed along dysmorphic lymphatics in areas densely concentrated with hyaluronan, an interstitial glycosaminoglycan that depends on lymphatic drainage for clearance. We illustrated similar findings in transplanted mouse lungs and hearts, which were accompanied by lymphographic findings of graft lymphedema. Using unsupervised clustering, we found a subset of stromal cells present in fibrotic syngeneic mouse lung grafts and human lung and heart grafts with chronic rejection that coexpressed hyaluronan synthase 1 and interleukin-1 receptor 1. Shortly after reperfusion of syngeneic mouse lung grafts, we identified neutrophilic expression of interleukin-1 β ( Il1b ) as a driver of hyaluronan synthase 1 up-regulation. We found interleukin-1–mediated hyaluronan accumulation as a mechanism driving fibrosis that occurred independent of alloimmunity in the setting of lymphatic disruption after transplantation. Development of fibrotic remodeling in transplanted mouse lungs was inhibited by preventing hyaluronan synthesis through the administration of 4-methylumbilliferone, accelerating lymphangiogenesis with pharmacologic activation of VEGF (vascular endothelial growth factor) receptor-3, or inhibiting interleukin-1 receptor 1 signaling in the graft. These therapeutic interventions lay the foundation for future clinical strategies to prevent chronic rejection.
- 25 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (838) , eadu0358
Lymphatic disruption drives lung transplant fibrosis through interleukin-1–mediated hyaluronan accumulation
The consequence of lymphatic disruption during transplantation of solid organs remains unknown. Long-term survival after organ transplantation is limited by chronic rejection, a poorly understood process involving fibrotic remodeling and functional decline of the graft. Here, we found that transplanted human lungs and hearts with chronic rejection exhibited fibrosis distributed along dysmorphic lymphatics in areas densely concentrated with hyaluronan, an interstitial glycosaminoglycan that depends on lymphatic drainage for clearance. We illustrated similar findings in transplanted mouse lungs and hearts, which were accompanied by lymphographic findings of graft lymphedema. Using unsupervised clustering, we found a subset of stromal cells present in fibrotic syngeneic mouse lung grafts and human lung and heart grafts with chronic rejection that coexpressed hyaluronan synthase 1 and interleukin-1 receptor 1. Shortly after reperfusion of syngeneic mouse lung grafts, we identified neutrophilic expression of interleukin-1 β ( Il1b ) as a driver of hyaluronan synthase 1 up-regulation. We found interleukin-1–mediated hyaluronan accumulation as a mechanism driving fibrosis that occurred independent of alloimmunity in the setting of lymphatic disruption after transplantation. Development of fibrotic remodeling in transplanted mouse lungs was inhibited by preventing hyaluronan synthesis through the administration of 4-methylumbilliferone, accelerating lymphangiogenesis with pharmacologic activation of VEGF (vascular endothelial growth factor) receptor-3, or inhibiting interleukin-1 receptor 1 signaling in the graft. These therapeutic interventions lay the foundation for future clinical strategies to prevent chronic rejection.
- Open Access
- 26 August 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (12) , 2515-2528
Tolerogenic lung allograft microenvironment suppresses pathogenic tissue remodeling following respiratory virus infection in mice
- 26 August 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (12) , 2515-2528
Open AccessTolerogenic lung allograft microenvironment suppresses pathogenic tissue remodeling following respiratory virus infection in mice
- Open Access
- 21 November 2022
- Published by Elsevier in Transplantation Reports
- Vol. 7 (4)
Donor substance use and lung transplantation: A single center experience
- 21 November 2022
- Published by Elsevier in Transplantation Reports
- Vol. 7 (4)
Open AccessDonor substance use and lung transplantation: A single center experience
- 29 April 2022
- Published by BMJ in BMJ Case Reports
- Vol. 15 (4) , e247033
Gemella morbillorum mitral valve endocarditis in a patient with a history of mitral valve annuloplasty
A woman with a history of congenital heart disease status post multiple valve operations including mitral valve repair presented with 2 months of low back pain and general malaise. Blood cultures returned positive for Gram-positive cocci. While transthoracic echocardiography did not identify vegetations, transoesophageal echocardiography visualised vegetations on the patient’s mitral valve, which had previously undergone repair with annuloplasty. The patient was found to have infectious endocarditis (IE), caused by Gemella morbillorum. The patient was treated with over 6 weeks of intravenous antibiotics. Cases of Gemella-associated IE are rare and largely relegated to case reports. This report aims to contribute to the literature regarding this subject, and to further characterise the presentation and treatment of Gemella-associated IE. Additionally, this report emphasises the importance of maintaining a high suspicion of IE in a patient with non-specific malaise in the setting of prior cardiac valve operation.
- 29 April 2022
- Published by BMJ in BMJ Case Reports
- Vol. 15 (4) , e247033
Gemella morbillorum mitral valve endocarditis in a patient with a history of mitral valve annuloplasty
A woman with a history of congenital heart disease status post multiple valve operations including mitral valve repair presented with 2 months of low back pain and general malaise. Blood cultures returned positive for Gram-positive cocci. While transthoracic echocardiography did not identify vegetations, transoesophageal echocardiography visualised vegetations on the patient’s mitral valve, which had previously undergone repair with annuloplasty. The patient was found to have infectious endocarditis (IE), caused by Gemella morbillorum. The patient was treated with over 6 weeks of intravenous antibiotics. Cases of Gemella-associated IE are rare and largely relegated to case reports. This report aims to contribute to the literature regarding this subject, and to further characterise the presentation and treatment of Gemella-associated IE. Additionally, this report emphasises the importance of maintaining a high suspicion of IE in a patient with non-specific malaise in the setting of prior cardiac valve operation.
- Open Access
The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis
Colorectal cancer (CRC) is the third most common malignancy and the second most common cause of cancer-related mortality worldwide. A total of 20% of CRC patients present with distant metastases, most frequently to the liver and lung. In the primary tumor, as well as at each metastatic site, the cellular components of the tumor microenvironment (TME) contribute to tumor engraftment and metastasis. These include immune cells (macrophages, neutrophils, T lymphocytes, and dendritic cells) and stromal cells (cancer-associated fibroblasts and endothelial cells). In this review, we highlight how the TME influences tumor progression and invasion at the primary site and its function in fostering metastatic niches in the liver and lungs. We also discuss emerging clinical strategies to target the CRC TME.
Open AccessThe Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis
Colorectal cancer (CRC) is the third most common malignancy and the second most common cause of cancer-related mortality worldwide. A total of 20% of CRC patients present with distant metastases, most frequently to the liver and lung. In the primary tumor, as well as at each metastatic site, the cellular components of the tumor microenvironment (TME) contribute to tumor engraftment and metastasis. These include immune cells (macrophages, neutrophils, T lymphocytes, and dendritic cells) and stromal cells (cancer-associated fibroblasts and endothelial cells). In this review, we highlight how the TME influences tumor progression and invasion at the primary site and its function in fostering metastatic niches in the liver and lungs. We also discuss emerging clinical strategies to target the CRC TME.
- 26 June 2020
- Published by Elsevier in Journal of Surgical Research
- Vol. 255, 332-338
Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass for Lung Transplantation
- 26 June 2020
- Published by Elsevier in Journal of Surgical Research
- Vol. 255, 332-338
Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass for Lung Transplantation
- 10 September 2018
- Published by Wiley in Birth Defects Research
- Vol. 111 (14) , 982-990
Understanding how the concentration of neighborhood advantage and disadvantage affects spina bifida risk among births to non‐Hispanic white and Hispanic women, Texas, 1999–2014
Background: This is the first study to utilize the index of concentration at the extremes (ICE) to examine risk factors for spina bifida in Texas. The ICE is a useful measure for providing the degree to which residents in a certain area are concentrated into groups at the extremes of disadvantage and privilege. We introduce two novel ICE measures (language and nativity), and three existing ICE measures (race/ethnicity, income, and education), which we applied specifically to Texas residents.Methods: We used multivariable mixed‐model Poisson regression analyses to estimate spina bifida birth prevalence and prevalence ratios among singleton live births in Texas, 1999–2014, for each of our ICE measures. Maternal census tract at delivery was included in the models as a random effect. Analyses were stratified by maternal race/ethnicity (Hispanics and non‐Hispanic whites). Live births served as denominators for each category.Results: Among non‐Hispanic white women, those in the most disadvantaged versus the advantaged census tract quintile had adjusted relative risk between 1.6 and 8.5 for having a baby affected by spina bifida. However, Hispanic women in the most disadvantaged versus advantaged census tract quintile for four ICE measures had a 33% to 87% lower risk of having an affected pregnancy.Conclusions: Findings suggest spina bifida risk is associated with neighborhood disadvantage or advantage, and that relationship seems to vary by race‐ethnicity. The varied associations between ICE measures and spina bifida by race/ethnicity highlights the importance of using targeted interventions in the prevention of spina bifida.
- 10 September 2018
- Published by Wiley in Birth Defects Research
- Vol. 111 (14) , 982-990
Understanding how the concentration of neighborhood advantage and disadvantage affects spina bifida risk among births to non‐Hispanic white and Hispanic women, Texas, 1999–2014
Background: This is the first study to utilize the index of concentration at the extremes (ICE) to examine risk factors for spina bifida in Texas. The ICE is a useful measure for providing the degree to which residents in a certain area are concentrated into groups at the extremes of disadvantage and privilege. We introduce two novel ICE measures (language and nativity), and three existing ICE measures (race/ethnicity, income, and education), which we applied specifically to Texas residents.Methods: We used multivariable mixed‐model Poisson regression analyses to estimate spina bifida birth prevalence and prevalence ratios among singleton live births in Texas, 1999–2014, for each of our ICE measures. Maternal census tract at delivery was included in the models as a random effect. Analyses were stratified by maternal race/ethnicity (Hispanics and non‐Hispanic whites). Live births served as denominators for each category.Results: Among non‐Hispanic white women, those in the most disadvantaged versus the advantaged census tract quintile had adjusted relative risk between 1.6 and 8.5 for having a baby affected by spina bifida. However, Hispanic women in the most disadvantaged versus advantaged census tract quintile for four ICE measures had a 33% to 87% lower risk of having an affected pregnancy.Conclusions: Findings suggest spina bifida risk is associated with neighborhood disadvantage or advantage, and that relationship seems to vary by race‐ethnicity. The varied associations between ICE measures and spina bifida by race/ethnicity highlights the importance of using targeted interventions in the prevention of spina bifida.